Article Information
History
- March 5, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Negin Holland, MRCP1,2,*,
- Maura Malpetti, PhD1,
- Timothy Rittman, FRCP, PhD1,2,
- Elijah E Mak, PhD3,
- Luca Passamonti, MRCP, PhD1,4,
- Sanne S Kaalund, PhD1,
- Frank H. Hezemans, PhD1,6,
- P. Simon Jones, MSc1,
- George Savulich, PhD3,
- Young T. Hong, PhD5,
- Tim D. Fryer, PhD1,5,
- Franklin I. Aigbirhio, DPhil1,
- John T O’Brien, FRCPsych, DM2,3 and
- James B Rowe, FRCP, PhD1,2,6
- 1Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0SZ
- 2Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, CB2 0QQ
- 3Department of Psychiatry, University of Cambridge, School of Clinical Medicine, Cambridge Biomedical Campus, UK, CB2 0QQ
- 4Istituto di Bioimmagini e Fisiologia Molecolare (IBFM), Consiglio Nazionale delle Ricerche (CNR), 20090, Milano, Italy
- 5Wolfson Brain Imaging Centre, University of Cambridge, UK, CB2 0QQ
- 6Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, UK, CB2 7EF
- ↵*Corresponding Author:
Dr Negin Holland MRCP, BSc, Association of British Neurologists Clinical Research Fellow, University of Cambridge, Herschel Smith Building, Robinson Way, Cambridge, CB2 0SZ, UK; Tel: +441223764047; Nda26{at}cam.ac.uk
Posted March 05, 2021.
Molecular pathology and synaptic loss in primary tauopathies: [18F]AV-1451 and [11C]UCB-J PET study
